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Cognitive dysfunction in Parkinson’s disease contributes to disability, caregiver strain, and diminished quality of life. Cognitive
rehabilitation, a behavioral approach to improve cognitive skills, has potential as a treatment option to improve and maintain
cognitive skills and increase quality of life for those with Parkinson’s disease-related cognitive dysfunction. Four cognitive
rehabilitationprogramsinindividualswithPDareidentiﬁedfromtheliterature.Characteristicsoftheprogramsandoutcomesare
reviewed and critiqued. Current studies on cognitive rehabilitation in PD demonstrate feasibility and acceptability of a cognitive
rehabilitation program for patients with PD, but are limited by their small sample size and data regarding generalization of eﬀects
overthelongterm.BecausePDinvolvesprogressiveheterogeneousphysical,neurological,andaﬀectivediﬃculties,futurecognitive
rehabilitation programs should aim for ﬂexibility and individualization, according to each patient’s strengths and deﬁcits.
1.Introduction
Cognitive dysfunction is a nonmotor feature of Parkinson’s
disease (PD) that contributes signiﬁcantly to disability, care-
giver strain, and diminished quality of life over the course of
the disease [1, 2]. While there is not a “signature” deﬁcit that
characterizes cognitive dysfunction in PD, common features
include executive dysfunction, visuospatial dysfunction, and
short-termmemorydeﬁcits.Evenin theearliest stagesofPD,
cognitive decline, and executive dysfunction in particular, is
present in up to a third of patients [3]. An estimated 50% of
individuals with PD have mild cognitive impairments in the
absence of dementia [4, 5], and 25–30% of individuals with
PD meet criteria for dementia [6, 7].
With advances in medical and surgical interventions for
motor symptoms, individuals with PD are living longer and
facing greater disability related to cognitive impairments.
Accordingly, there is a corresponding need to address
cognitive changes therapeutically. Yet, to date, there are
no deﬁnitive treatments for cognitive dysfunction in PD
[8]. Medication trials, aimed at slowing progression of
cognitive decline or improving cognitive performance, have
had variable success in decreasing functional impairment
[8, 9]. Alternative or adjunctive behavioral interventions for
cognitive dysfunction have the potential to reduce disability
and improve quality of life in individuals with PD and
their caregivers. Originally developed to improve cognitive
functioning after traumatic brain injury (TBI), cognitive
rehabilitation programs have recently been adapted for
other neurological conditions [10]. However, there are no
standardized guidelines regarding the types of strategies that
oﬀer the most beneﬁcial outcomes, or the types of cognitive2 Parkinson’s Disease
impairments or stages of cognitive decline for which treat-
ment is most beneﬁcial that would guide application in PD.
Cognitive rehabilitation, a behavioral treatment ap-
proach for individuals with cognitive dysfunction, is de-
signedtoreducefunctionalimpairmentandincreaseengage-
ment in daily adaptive activities. Although there is variation
across programs, the essential elements of cognitive rehabil-
itation consist of basic skills training related to performance
of vocational, social, and adaptive daily living skills. Subsets
of cognitive training programs target improvements in
speciﬁc cognitive domains, including visuospatial awareness,
attention, working memory, or executive functioning, which
are the essential cognitive skills to complete daily living
tasks.Cognitiverehabilitationstrategiesconsistofrestorative
or compensatory techniques. Restorative techniques focus
on strategies to improve cognitive functioning to closer
to the patient’s level before there was an obvious decline.
Speciﬁcrestorativeskillsincludetechniquestoimproverecall
of information over increasing periods of time (spaced
retrieval) or using less intense cues (vanishing cues), com-
puterized drills and repeated prompting to improve memory
and attention and recall of remote memories (reminiscence
therapy). Compensatory techniques provide strategies that
organize information to improve recall and learning and
provide instruction in self-management strategies. Com-
pensatory techniques also include using multiple senses to
improve learning and retrieval, procedural training to learn
increasingly more complex behaviors, and external cues
such as memory notebooks or calendars to improve recall.
Programs may also teach, in-person or with the aid of com-
puterized devices and software, strategies to improve self-
management, such as problem solving, time management,
and compensation for impaired memory [11]. Examining
whichcognitive strategieshavethemost beneﬁcialimpacton
cognitive functioning, and adaptive living skills for PD could
be the initial step in evaluating the feasibility and utility of
cognitive rehabilitation programs in this population.
The short- and long-term cognitive impairments fol-
lowing traumatic brain injury (TBI) are optimal targets
for cognitive remediation, and positive outcomes following
cognitive rehabilitation have been consistently demonstrated
[10]. Standard TBI rehabilitation programs include training
in strategies to compensate for attention deﬁcits, visual
scanning (for visual neglect), apraxia, language and func-
tional communication, and mild memory deﬁcits [12]. As
TBI patients often have executive dysfunction, inclusion
of emotional self-regulation and motivation skills into
problem-solving skills has been shown to be eﬀective in
TBI cognitive training programs [10, 13]. While numerous
cognitive rehabilitation programs have been developed for
TBI, which is an acquired brain injury; less research has
focused on progressive neurological disease.
Cognitive rehabilitation programs for neurological dis-
orders, including studies in Alzheimer’s disease (AD), vary
considerably in content (memory, learning, executive func-
tioning, attention), administration (individual, group, com-
puterized), timing (1 session versus 15 sessions) and setting
(inpatient versus outpatient) [14, 15]. In Alzheimer’s disease
(AD), the studies have used primarily restorative strategies
with both individual and group cognitive training pro-
g r a m sh a v ed e m o n s t r a t e dp o s i t i v eo u t c o m e s[ 14, 15]. These
cognitive training programs in AD provide evidence that
patients with progressive neurological conditions can beneﬁt
from retraining. However, memory-training strategies are
theprimarycognitiveskillevaluatedinADandrehabilitation
studies have not evaluated executive functioning in this
population.
Lack of agreement regarding the deﬁnitions of PD-
cognitive dysfunction and procedures (e.g., structured inter-
views, expert consensus, or neuropsychological tests) that
best identify cognitive changes and impairments is a major
challenge to treatment. This is particularly evident in PD-
Mild Cognitive Impairment (PD-MCI), which has been
deﬁned inconsistently across studies. In general, MCI refers
to an intermediate severity of acquired cognitive dysfunction
between the cognitive status of “within normal limits” and
“demented.” Whereas the MCI classiﬁcation was developed
and validated for conversion to Alzheimer’s disease (AD)
[16], similar nomenclature and criteria were proposed for
PD-MCI [17].
Prevalence of PD-MCI and more subtle cognitive dys-
function in PD ranges from 21% to 55%, depending on
the duration of the disease and which PD-MCI criteria and
neuropsychological measures were used [4, 17, 18]. PD-MCI
criteria have been outlined as the presence of a subjective
report of cognitive problems by the patient or caregiver
and performance at least 1.5 standard deviations below the
age-corrected mean score in one cognitive domain without
impairments in activities of daily living [17]. On the basis of
these criteria, 21% of PD patients met criteria for PD-MCI
and 17% met criteria for PDD [17].
In patients with PD-MCI, executive dysfunction/atten-
tion and memory impairment are the most prevalent deﬁcits
reported [4, 17]. By contrast, when PD-MCI is deﬁned
as performance that is only one standard deviation below
the age-corrected mean across several neuropsychological
measures[19],53%ofPDpatientswereclassiﬁedasPD-MCI
and the amnesic subtype was most prevalent, followed by
the executive function and visuospatial subtypes. However,
neither of these PD-MCI criteria identiﬁes individuals whose
test performance is signiﬁcantly declined from a higher
premorbid baseline but has yet to fall one or more standard
deviations below normative test performance.
Cognitive deﬁcits are noticed in daily life when they
result in impaired performance in job-related duties, activ-
ities of daily living, and other activities that contribute
to an individual’s level of independence and well-being.
For example, safety, ﬁnancial planning and paying bills,
driving, and occupational performance can be of concern
in patients who demonstrate impairments in executive
functions [20–23]. Accordingly, an approach to classiﬁcation
of cognitive dysfunction that overcomes the limitations of
normative assessments focuses on functional change. With
this approach, a functional change in performance that does
not meet the PD-MCI criteria is described as subtle cognitive
dysfunction [24]. Thus, individuals who have normal psy-
chometricperformancebutwhousecompensationstrategies
orincreasedeﬀorttoavoidthefunctionalimpactofcognitiveParkinson’s Disease 3
deﬁcits would be captured with this classiﬁcation. It would
be helpful to identify what types of impairments from subtle
to PD-dementia are most likely to beneﬁt from cognitive
rehabilitation.
This integrative paper provides an overview of the types
of cognitive impairments that are targeted in rehabilitation
for cognitive dysfunction in PD and compares the content
and delivery methods of cognitive rehabilitation interven-
tions applied to patients with PD. Strengths and limitations
of the current literature and future directions for cognitive
rehabilitation in PD are discussed.
2. Methods
To identify relevant studies for the integrative review,
keyword searches of abstract and titles were conducted in
the PubMed and PsycINFO databases for studies published
prior to July 2011. We used search terms (1) “Parkinson’s
disease” and “cognitive training”, (2) “Parkinson’s disease”
and “cognitive rehabilitation”, (3) “Parkinson’s disease”
and “cognitive remediation,” (4) “Parkinson’s disease” and
“training” and “executive.” Articles were included if they
were original research in English, included individuals with
Parkinson’s disease, and described any type of intervention
for cognitive functioning with pre- and postassessments.
3. Results
The PubMed search yielded a total of 18 unique articles and
3 additional studies were found in the PsycINFO database.
Of the 21 abstracts reviewed, 17 were excluded. Reasons
for exclusion were not reporting original research (e.g.,
review manuscripts, n = 5), not being in English (n =
2), not reporting cognitive rehabilitation interventions (e.g.,
interventions for gait, n = 6), not including pre- and
postsassessments (n = 2), and subject population not
individuals with Parkinson’s disease (n = 2).
3.1. Cognitive Rehabilitation in Parkinson’s Disease. To date,
there have been four reports of cognitive rehabilitation or
training programs for patients with PD. Two are open-
trial pilot studies, and two are small randomized controlled
trials (RCTs) of cognitive rehabilitation programs targeting
executive functioning, attention, and visuospatial abilities
(see Table 1).
In Sinforiani and colleagues’ open trial [25], 20 patients
with idiopathic PD who were enrolled in a day hospital
motor rehabilitation program completed a computerized
cognitive rehabilitation program that focused on improving
attention, abstract reasoning, and visuospatial abilities. After
cognitive training, PD patients had signiﬁcantly improved
verbal ﬂuency, immediate and delayed logical memory, and
visuospatial reasoning compared with their baseline assess-
ments;thesegainsweremaintainedafter6months.Although
no diﬀerences were found after cognitive rehabilitation on
measures of short-term memory, set-shifting or inhibition,
this study suggests the potential for patients with PD to
complete cognitive rehabilitation, improve performance on
cognitive assessments, and maintain those gains. However,
the small sample size, lack of a control comparison group,
inpatient setting, and absence of a measurement of everyday
functioning limit conclusions with respect to overall cogni-
tive and functional improvement enhanced by the cognitive
rehabilitation program and generalization of these ﬁndings
to the larger population of PD patients who are not in an
inpatient setting.
Mohlman et al. [26]c o m p l e t e das m a l l( n = 14) open
trial to test the feasibility of an attention process training
intervention for patients with a minimental state exam
(MMSE) score >23 and idiopathic PD. The intervention
consisted of in-person training with practice exercises and
worksheets on attention tasks. Daily at-home practice exer-
cises were also encouraged for all participants. Fourteen
participants completed the program, and the self-report
ratings on feasibility yielded positive results. The average
rankings were between “some” to “much” perception of
progress in improving their attention and enjoyment. The
author reported that the participants improved on the mea-
sures of executive skills consisting of Digit Span backward,
Stroop Color Word Test, Trail Making B, and Controlled
Oral Word Association Test. This open trial successfully
demonstrated the feasibility of administering an in-person
cognitive training program and patients’ acceptance of
training. However, because of the small sample, study design
and minimal outcomes measures, in addition to the lack of
control group and long-term followup, conclusions as to the
eﬀectiveness of the intervention and translation into short-
term or long-term functional outcomes are limited.
The two RCTs investigating cognitive rehabilitation in
PD included relatively small sample sizes; however, these
studies improved upon the literature by comparing the ben-
eﬁts of cognitive training programs to usual care received by
individuals with PD. Sammer and colleagues [27]c o n d u c t e d
an RCT for cognitive training of executive functions in the
context of an inpatient rehabilitation program for PD. Par-
ticipants were randomized to receive standard rehabilitation
(occupational therapy, physiotherapy, and physical treat-
ment) or standard rehabilitation plus a cognitive training
program.Thecognitivetrainingprogramconsistedof10ses-
sions focused on facilitating working memory functioning,
including search tasks, matrices, puzzles, speech production,
picture completion, and storytelling. The 12 patients who
completed the program demonstrated improved executive
function compared with the 14 patients who completed only
the standard treatment, even after controlling for premorbid
intelligence, mood, age, dopaminergic medications, and dis-
ease severity. Additionally, the standard treatment arm had
reduced working memory performance; whereas patients
who received cognitive training maintained their baseline
scores aftertreatment. This pilot RCT study was limited by
a small sample size and lack of long-term assessments to
evaluate maintenance of gains. Furthermore, the study did
notaddresswhetherthetreatmentcontributedtogeneralized
improvements in daily activities or outside the inpatient
setting.
Another small RCT compared a 4-week outpatient
computer-based cognitive training program to a speech4 Parkinson’s Disease
Table 1: Cognitive training programs for patients with Parkinson’s disease.
Author(s) Total N Randomized
study
Length of
treatment Treatment Cognitive targets Outcome measures Results
McKinlay
et al. [24] 20 No
12 1-hour
sessions over
6w e e k s
Computerized
software for
neuropsycho-
logical
training
Attention,
abstract
reasoning,
visuospatial
Babcock’s story,
FAS, Raven
matricies, Corsi-test,
WCST and Stroop
PD patients improved on
Babcock’s story, FAS∗ and
Raven matrices and at 6
months gains maintained.
No diﬀerences from
baseline on digit span,
Corsi-test, WCST∗ and
Stroop after training
Sinforiani
et al. [25] 14 No
4 90-minute
sessions over
4w e e k s
Attention
process training
Sustained,
selective,
alternating, and
divided attention
Digits backward,
Stroop, Trail Making
Test B, FAS
Improvement on digits
backward, Stroop, Trail
Making Test B and FAS
post treatment. On
average, self-ratings were
given for “some” to
“much” progress,
enjoyment and eﬀort in
the program
Mohlman
et al. [26] 26
Yes
12 cognitive
training 14
standard
treatment
10 30-minute
sessions
during a 3-4
week
rehabilitation
hospital stay.
Working
memory tasks
Executive
functions BADS
Cognitive training group
signiﬁcant improvement
on BADS∗
Sammer
et al. [27] 33
Yes
18 cognitive
training
group15
control group
12 45-minute
sessions over
4w e e k s
Computerized
software and
paper-pencil
exercises
Attention/
working memory,
memory,
psychomotor
speed, executive
functions and
visuospatial
Digits Forward,
Stroop, ROCFT,
Semantic ﬂuency,
Trail Making B,
TOL, PDQ-39 and
CDS
Cognitive Training group
had more improvement
than Control Group after
treatment on the Digit
Span Forward, Stroop
Word Test, ROCFT,
Semantic ﬂuency, Trail
Making B and TOL. No
group diﬀerences on the
PDQ-39 or CDS
∗Note: BADS: behavioral assessment of dysexecutive syndrome, FAS: phonological word ﬂuency test; WCST: wisconsin card sorting task; ROCFT: Rey-
Osterrieth complex ﬁgure test, TOL: tower of London, PDQ-39: Parkinson’s disease questionnaire-39; CDS: cognitive diﬃculties in ADLs.
therapy program matched on participation time [28]. All
33 participants had idiopathic PD and MMSE greater than
23. Among the subjects, 50% met criteria for MCI; but
MCI was not a signiﬁcant predictor in the outcome analysis.
Following the 4-week intervention, the 18 participants
in the cognitive training group demonstrated improved
performance on attention, information processing, visual
memory, verbal ﬂuency, visuoconstruction, and executive
functioning measures. Participants with and without MCI
improved equally well-following treatment. The study had
no long-term outcome assessments.
4. Conclusions
Cognitive rehabilitation programs are increasingly recog-
nized as beneﬁcial alternatives to or adjunctive therapy
for medications for improving speciﬁc types of cogni-
tive dysfunction in patients with neurological disorders
or maintaining patients at their current level; however,
there is limited evidence for the eﬀectiveness of cognitive
rehabilitation in PD. The cognitive training programs for
TBIandAD,whichutilizethemostwell-developedprograms
have shown improvements in memory, attention, executive
functioning, and problem solving [10], have demonstrated
the feasibility of these retraining programs in either acquired
or progressively deteriorating neurological conditions. Well-
controlled,randomized largerscaleinvestigations areneeded
for PD and other neurologically impaired population that
take into account the speciﬁc disease characteristics of the
population (e.g., duration of motor severity, medications),
the speciﬁc cognitive domains aﬀected in the population
(e.g., executive dysfunction, visuospatial), the objective cog-
nitive assessments, daily functioning assessments, and long-
term outcome assessments.
Although the current studies in PD are limited in sample
size, it appears that cognitive training programs are both
feasible and well accepted by PD patients. The cognitive
targets of the reviewed pilot studies focus on attention and
executive impairments in nondemented patients using both
computers and in-person interventions. As the literatureParkinson’s Disease 5
on cognitive rehabilitation programs grows, it would be
beneﬁcial for studies to use similar assessments to enhance
comparisons between studies and to include both measures
of neuropsychological and everyday functioning to evaluate
the generalizability of the program into the patient’s daily
functioning. Based on the current literature, the eﬀectiveness
of cognitive training to demonstrate targeted short-term
improvement on objective assessments following rehabilita-
tion is promising [20–28]; however, long-term assessments
of cognitive rehabilitation for patients with PD are needed.
Both in-person and computerized training appear feasible
but more information is needed on PD-related patient
characteristics that predict success in cognitive rehabilitation
interventions (e.g., age, length since diagnosis, type or sever-
ity of cognitive impairments). Executive dysfunction, which
is an early indicator of PD-related cognitive decline and has
a pervasive impact on daily functioning, has been identiﬁed
as a target for cognitive rehabilitation in other populations.
Accordingly, cognitive rehabilitation programs, particularly
those that focus on improving executive functioning, have
the potential to help patients with PD maintain a higher level
of adaptive living skills and quality of life.
Future cognitive rehabilitation outcomes studies in PD
will need to address the limitations uncovered in pro-
grams developed for other neurologically impaired pop-
ulations and the obstacles inherent in working with PD
patients. Cognitive rehabilitation is often time-consuming
for patients, caregivers, and therapists and can be costly to
implement. In addition to these logistical obstacles is the
lack of ecologically valid outcome measures to demonstrate
improvement in patients’ daily functioning or generalization
of their newly acquired abilities to other areas of daily
living. Well-controlled and described randomized studies
usingappropriatecontrolgroupswithlonger-termfollow-up
evaluations including ecologically valid outcome measures
would be an initial step to demonstrate actual eﬃcacy of
cognition rehabilitation in PD.
Additionally, PD itself poses several inherent obstacles
for success in terms of cognitive rehabilitation. Researchers
will also need to address these issues when developing
future cognitive rehabilitation programs for patients with
PD, including the heterogeneity of cognitive impairment,
variability of functioning for patients with on/oﬀ ﬂuc-
tuations, cooccurring depression and anxiety, apathy, the
mobility issues that restrict access to biweekly individualized
programs, and the optimal disease stage in which improve-
ments in cognitive functioning would be most beneﬁcial.
Personalized approaches to tailor treatment to individual
strengths and deﬁcits are recommended. If skills learned in
cognitive rehabilitation carry over into everyday functioning
and improve problem-solving and adaptive abilities, the
programs could create positive and long-lasting beneﬁts
for patients by improving quality of life and potentially
decreasing caregiver burden.
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